SCHEMBL16827418

SCHEMBL16827418

CCCCc1ccc(N2CCc3cc(OC)ccc3C2=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 7/20 0.47
▸ NPC1 O15118 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ MCHR1 Q99705 1/20 0.42
▸ PDE4A P27815 1/20 0.41
▸ PDE4B Q07343 1/20 0.41
▸ PDE4C Q08493 1/20 0.41
▸ PDE4D Q08499 1/20 0.41
▸ DRD2 P14416 1/20 0.41
▸ HTR2A P28223 1/20 0.41
▸ HTR2C P28335 1/20 0.41
▸ HTR2B P41595 1/20 0.41
▸ SIGMAR1 Q99720 1/20 0.41
▸ NR1H3 Q13133 2/20 0.41
▸ F10 P00742 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ GRIN1 Q05586 1/20 0.40
▸ GRIN2B Q13224 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16848070 0.97 AOC3 (0.46) AOC3NPC1PKMRAB9AMCHR1
SCHEMBL16848246 0.87 AOC3 (0.48) AOC3NPC1PKMRAB9ADRD2
SCHEMBL16827580 0.85 AOC3 (0.46) AOC3NPC1PKMRAB9ADRD2
SCHEMBL16848192 0.84 AOC3 (0.48) AOC3NPC1PKMRAB9ADRD2
SCHEMBL16827555 0.83 AOC3 (0.48) AOC3NPC1PKMRAB9ADRD2
SCHEMBL16827378 0.82 CYP24A1 (0.49) AOC3NPC1PKMRAB9ADRD2
SCHEMBL16848194 0.82 AOC3 (0.49) AOC3NPC1PKMRAB9APDE4A
SCHEMBL16848202 0.82 AOC3 (0.61) AOC3NPC1PKMRAB9APDE4A
SCHEMBL29438611 0.81 PDE4A (0.55) AOC3NPC1PKMRAB9APDE4A
SCHEMBL29438613 0.81 PDE4A (0.55) AOC3NPC1PKMRAB9APDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015092634-A1 1,2,3,4-TETRAHYDROISOQUINOLINE COMPOUNDS AND COMPOSITIONS AS SELECTIVE ESTROGEN RECEPTOR ANTAGONISTS AND DEGRADERS NOVARTIS AG (CH) 2015-06-25 — — WO disclosed
WO-2015092634-A1 1,2,3,4-TETRAHYDROISOQUINOLINE COMPOUNDS AND COMPOSITIONS AS SELECTIVE ESTROGEN RECEPTOR ANTAGONISTS AND DEGRADERS NOVARTIS AG (CH) 2015-06-25 — — WO disclosed
Send feedback